Quantification of somatic and spermatogenic cell proliferation in the testes of ruminants, using a proliferation marker and flow cytometry analysis

1998 ◽  
Vol 49 (7) ◽  
pp. 1275-1287 ◽  
Author(s):  
S. Blottner ◽  
H. Roelants
2006 ◽  
Vol 18 (2) ◽  
pp. 209
Author(s):  
M. A. Ramírez ◽  
E. Pericuesta ◽  
M. Pérez-Crespo ◽  
R. Fernández-González ◽  
P. N. Moreira ◽  
...  

Normally the majority of mammalian cells, including murine embryonic stem (mES) cells, are immersed in a low oxygen environment (hypoxia); however, mES are generally cultured in an atmosphere containing 21% O2 (normoxia). Such conditions may not be the most appropriate for mES propagation. We have tested the effects of hypoxia and culture on either feeder fibroblasts or gelatin substrate on mES cell growth and spontaneous differentiation. Two ES cell lines (R1 129/Sv from the laboratory of A. Nagy and MAR B6D2 F1 generated in our laboratory) were cultured under two different oxygen tensions (5 and 21%), and on two different substrates, 0.1% gelatin or murine embryonic fibroblasts (mEF). Cell cycle, cell proliferation, mRNA expression of pluripotency and differentiation markers, as well as spontaneous differentiation to cardiomyocytes, were monitored. For cell proliferation measurements, mES after 7 days of culture at the different conditions were labeled with 5-(and-6)-carboxyfluorescein diacetate succinimidyl ester, and cultured for up to three more days. Cells were then harvested for flow cytometry analysis every 24 h after labeling (Cell TraceTM CFSE Cell Proliferation Kit; Molecular Probes, Inc., Eugene, OR, USA). For cell cycle analysis, cells grown on mEF under the two different oxygen tensions were fixed after 10 days of culture, and then stained with propidium iodide/Triton-X-100 for flow cytometry analysis (Current Protocols in Cytometry, Chap. 7, 2001). The spontaneous differentiation of embryoid bodies [formed by ES cells in the absence of leukemia inhibitory factor (LIF)] to cardiomyocytes was also monitored. For mRNA expression of pluripotency (Nanog, Oct-3/4, Rex1, GENESIS, FGFR-4, TERF1, Cx43, and GLUT1) and differentiation markers (GATA4, GATA2, AFP, Msx-1, Brachyury, and Myf5), RT-PCR analysis was performed on mES cells from Day 0 to Day 10. Under hypoxia conditions, the proliferation of both types of mES cells was greater than under normoxia, independent of substrate used, and a higher number of apoptotic cells was detected. Moreover, only under normoxia conditions did mES cells lose the expression of pluripotency markers GENESIS and GLUT1. In addition, under lower oxygen tension, the rate of differentiation to beating cardiomyocytes was significantly lower on the feeder layer than that under normoxia (11.9% vs. 28.1%; P = 0.012). The feeder layer supported significantly higher cardiomyocyte formation when compared to 0.1% gelatin at 21% O2 (28.1% vs. 8.3%; P < 0.001). Our results show that normoxia may not be the most appropriate condition for mES cell propagation and that hypoxic culture may be necessary to maintain full pluripotency of mES cells.


2011 ◽  
Vol 57 (1) ◽  
Author(s):  
Rikke Christensen ◽  
David M. Owens ◽  
Anette Thomsen ◽  
Søren Pedersen ◽  
Uffe Birk Jensen

Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 329-329
Author(s):  
Sathisha Upparahallivenkateshaiah ◽  
Khan Sharmin ◽  
Ling Wen ◽  
Rakesh Bam ◽  
Xin Li ◽  
...  

Abstract Abstract 329 Accumulating evidence indicate that cellular metabolism and bi-products also play important roles in signaling associated with tumor cell proliferation, cell cycle, survival and drug resistance. The overall goal of the study was to molecularly characterize MM cells grown in the supportive bone marrow (BM) of clinically relevant SCID-hu or SCID-rab models. MM cells from 22 patients were engrafted in experimental animals. Following establishment of the disease as determined by increased production of circulating human immunoglobulins over a period of 2–4 months, MM cells were isolated from the implanted bones and subjected to global gene expression profile (GEP). Based on stringent criteria (e.g. p<0.05, >2 folds) we identified commonly overexpressed or underexpressed genes in post-engrafted MM cells compared to pre-engrafted cells from the same patients. Among the top upregulated genes we identified several factors associated with lipid metabolism including FABP5 (fatty acid-binding protein 5), SCD (stearoyl CoA desaturase 1), FADS1 (fatty acid desaturase 1) and SLC27A5 (a fatty acid transporter). Clinical GEP data of newly diagnosed patients from Total Therapy program at our institute revealed upregulation of these genes in high risk patients. We further sought to unravel the role of SCD in MM since it has been previously implicated in tumorigenesis and specific inhibitors are being developed for clinical use. SCD (encodes SCD1), is a rate-limiting enzyme responsible for synthesis of monounsaturated fatty acids. We hypothesized that while nutrient unsaturated fatty acids sufficiently satisfy requirement of most normal cells, growing MM cells demand higher content of these lipids for formation of new membrane phospholipids and immediate energy; therefore, inhibiting SCD1 may suppress MM cell survival and proliferation. Small-molecule inhibitor of SCD1 (BioVision) suppressed growth of 5 MM lines dose dependently; 72 hours IC50 ranged between 1μM (p<0.0006) and 2.5 μM (p<0.0001). At 1 μM the SCD1 inhibitor reduced MM cell proliferation by 70±4% (p<0.002) using thymidine incorporation assay and increased number of apoptotic MM cells from 10±1% in control cells to 27±8% in SCD1 inhibitor-treated cells (p<0.03), using annexin V/PI flow cytometry analysis. This inhibitor also disrupted cell cycle progression in MM cell lines as determined by flow cytometry analysis of DNA content. The Akt/mTOR and AMPK pathways, albeit opposing functions, are known central integrators of cellular metabolism and proliferation signaling. SCD1 inhibitor reduced phosphorylated AKT and increased phosphorylated AMPK in MM cells assessed by Western Blot. For in vivo experiments in SCID-rab mice, SCD1 inhibitor was constantly administered (1.25 μg/hour) by osmotic pumps directly connected to the implanted bones that had been engrafted with luciferase-expressing H929 MM cells (6 mice/group). SCD1 inhibitor suppressed MM growth by 60% (p<0.01) assessed by live-animal imaging and measurement of circulating levels of human immunoglobulins in mice sera. These findings suggest that intracellular modulators of lipid metabolism such as SCD1 are induced in MM cells by the supportive BM and mediate signals linking cellular metabolism, survival and proliferation. Disclosures: No relevant conflicts of interest to declare.


Molecules ◽  
2021 ◽  
Vol 26 (5) ◽  
pp. 1461
Author(s):  
Nuno Mariz-Ponte ◽  
Laura Regalado ◽  
Emil Gimranov ◽  
Natália Tassi ◽  
Luísa Moura ◽  
...  

Pseudomonas syringae pv. actinidiae (Psa) is the pathogenic agent responsible for the bacterial canker of kiwifruit (BCK) leading to major losses in kiwifruit productions. No effective treatments and measures have yet been found to control this disease. Despite antimicrobial peptides (AMPs) having been successfully used for the control of several pathogenic bacteria, few studies have focused on the use of AMPs against Psa. In this study, the potential of six AMPs (BP100, RW-BP100, CA-M, 3.1, D4E1, and Dhvar-5) to control Psa was investigated. The minimal inhibitory and bactericidal concentrations (MIC and MBC) were determined and membrane damaging capacity was evaluated by flow cytometry analysis. Among the tested AMPs, the higher inhibitory and bactericidal capacity was observed for BP100 and CA-M with MIC of 3.4 and 3.4–6.2 µM, respectively and MBC 3.4–10 µM for both. Flow cytometry assays suggested a faster membrane permeation for peptide 3.1, in comparison with the other AMPs studied. Peptide mixtures were also tested, disclosing the high efficiency of BP100:3.1 at low concentration to reduce Psa viability. These results highlight the potential interest of AMP mixtures against Psa, and 3.1 as an antimicrobial molecule that can improve other treatments in synergic action.


2021 ◽  
Vol 8 ◽  
pp. 148-154
Author(s):  
Jia-Long Fang ◽  
Frederick A. Beland ◽  
Yangshun Tang ◽  
Steve R. Roffler

Author(s):  
Kenji Nozaki ◽  
Yuki Fujioka ◽  
Daisuke Sugiyama ◽  
Jun Ishikawa ◽  
Masato Iida ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document